Why are we seeing so much more euglycemic DKA after the introduction of SGLT2 inhibitors? In this video I will go over why so many more Type 2 diabetic patients are coming in with DKA when this disease process was previously much more predominantly seen in Type 1 diabetic patients. I will briefly review the pathophysiology of DKA (it's a helpful thing to review imo!) and then we will see how SGLT2 inhibitors end up playing a role to create a relative insulin deficiency leading to euglycemic DKA!
💡 PLAYLISTS
Guides for medical students: [ Ссылка ]
Guides for residents/interns: [ Ссылка ]
Guides for using Epic: [ Ссылка ]
All my other videos: [ Ссылка ]
🎥 TOOLS I USE
Microphone - Samson Q2U [ Ссылка ]
Camera - Canon M50 Mark II [ Ссылка ]
Mouse - Razer Viper Wireless [ Ссылка ]
Keyboard - Cidoo ABM084 Gateron Pro Yellow [ Ссылка ]
Chair - SecretLabs Titan Regular Ash [ Ссылка ]
Video Recording - Open Broadcaster Software [ Ссылка ]
Editing Software - DaVinci Resolve [ Ссылка ]
Lighting - YICOE Softbox Lighting Kit [ Ссылка ]
Tablet - XP-PEN Deco 01 V2 [ Ссылка ]
Tripod - Ulanzi MT-34 Extendable Tripod / Selfie Stick [ Ссылка ]
❤️ CONNECT WITH ME
Website - [ Ссылка ]
Email - conanliumd@gmail.com
Twitter - [ Ссылка ]
Discord - [ Ссылка ]
